US2003138467A1PendingUtilityA1
Methods for improving the aesthetic appearance of skin
Est. expiryDec 27, 2021(expired)· nominal 20-yr term from priority
Inventors:Dmitri Ptchelintsev
A61P 39/06A61P 37/08A61P 29/00A61P 17/00A61Q 19/08A61Q 19/02A61P 17/16A61P 17/04A61K 8/498A61P 17/02
47
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
There are provided methods and compositions for improving the aesthetic appearance of akin, treating rosacea and/or telangiectasia, and treating the signs of dermatological aging. The method is directed to topically applying to an affected area an effective amount of mangostin, an analog thereof, or a combination thereof.
Claims
exact text as granted — not AI-modifiedWhat is claimed is
1 . A composition for treating skin comprising:
an ingredient represented by the following formula: wherein R 1 , R 2 , R 3 and R 4 may, independently, be a hydrogen atom; a carbohydrate; an acyl group, substituted or unsubstituted, straight-chain or branched, fully saturated or having one or more unsaturated bonds, and have from 1 to 22 carbon atoms; an alkyl group, substituted or unsubstituted, straight-chain or branched, fully saturated or having one or more unsaturated bonds, and have from 1 to 22 carbon atoms; an alkenyl group, substituted or unsubstituted, straight-chain or branched, fully saturated or having one or more unsaturated bonds, and have from 1 to 22 carbon atoms; an alkynyl group, substituted or unsubstituted, straight-chain or branched, fully saturated or having one or more unsaturated bonds, and have from 1 to 22 carbon atoms; a phenyl group, substituted or unsubstituted; a benzyl group, substituted or unsubstituted; a cycloalkyl group, substituted or unsubstituted, and have from 3 to 8 carbon atoms; a cycloalkenyl group, substituted or unsubstituted, and have from 4 to 8 carbon atoms; and an oxaalkyl, oxaalkenyl, or oxaalkynyl group having at least one oxygen atom in its backbone structure, substituted or unsubstituted, and straight-chained or branched; and a cosmetically acceptable vehicle.
2 . The composition of claim 1 , wherein at least two of R 1 , R 2 , R 3 and R 4 are hydrogen atoms.
3 . The composition of claim 1 , wherein R 1 is an alkyl group or an acyl group having from 1 to 12 carbon atoms, and wherein R 2 , R 3 and R 4 are each hydrogen atoms.
4 . The composition of claim 1 , wherein the composition is in a product form selected from the group consisting of aerosol spray, cream, dispersion, foam, gel, lotion, mask, mousse, ointment, powder, patch, pomade, solution, pump spray, stick, tape, and towelette.
5 . The composition of claim 1 , wherein the ingredient is present in an amount about 0.0001 w % to less than 100 wt % based on the total weight of the composition.
6 . The composition of claim 1 , wherein the ingredient is present in an amount about 0.0001 w % to about 90 wt % based on the total weight of the composition.
7 . The composition of claim 1 , wherein the ingredient is present in an amount about 0.01 w % to about 50 wt % based on the total weight of the composition.
8 . The composition of claim 1 , wherein the ingredient is present in an amount about 0.5 w % to about 20 wt % based on the total weight of the composition.
9 . The composition of claim 1 , wherein the ingredient is 1,3,6-trihydroxy-7-methoxy-2,8-di(3-methyl-2-butenyl)xanthone.
10 . A method for treating a skin condition selected from the group consisting of rosacea, telangiectasia, dermatological signs of aging and any combination thereof, the method comprising topically applying to an affected area an effective amount of the composition of claim 1 .
11 . The method of claim 10 , wherein the skin condition is rosacea.
12 . The method of claim 10 , wherein the skin condition is telangiectasia.
13 . The method of claim 12 , wherein the telangiectasia includes the appearance of spider veins, broken capillaries or if both.
14 . The method of claim 10 , wherein the skin condition is the dermatological signs of aging.
15 . The method of claim 14 , wherein the dermatological signs of aging includes at least one of skin fragility; loss of collagen and/or elastin; skin atrophy; appearance and/or depth of lines and/or wrinkles; fine lines; skin discoloration; skin fatigue and/or stress; loss of skin tone, clarity or luster; loss of skin firmness; poor skin texture; loss of skin elasticity and/or resiliency; and thin skin.
16 . The method of claim 10 , wherein the composition is applied for an effective period of time.
17 . The method of claim 10 , wherein the composition is applied daily for about 1 week.
18 . The method of claim 10 , wherein the composition is applied daily for about 2 weeks.
19 . A method for improving the aesthetic appearance of skin, the method comprising topically applying to the skin an effective amount of the composition of claim 1 .
20 . The method of claim 19 , wherein the composition is applied for an effective period of time.
21 . The method of claim 19 , wherein the composition is applied daily for about 2 weeks.
22 . The method of claim 19 , wherein the ingredient is present in an amount about 0.01 w % to about 50 wt % based upon the total weight of the composition.
23 . The method of claim 19 , wherein the ingredient is 1,3,6-trihydroxy-7-methoxy-2,8-di (3-methyl-2-butenyl) xanthone.
24 . A method for treating sensitive skin, the method comprising topically applying to an affected area of the skin an effective amount of the composition of claim 1 .
25 . The method of claim 24 , wherein the composition is applied for an effective period of time.
26 . The method of claim 24 , wherein the composition is applied daily for about 2 weeks.
27 . The method of claim 24 , wherein the ingredient is present in an amount about 0.01 w % to about 50 wt % based on the total weight of the composition.
28 . The method of claim 19 , wherein the ingredient is 1,3,6-trihydroxy-7-methoxy-2,8-di (3-methyl-2-butenyl) xanthone.
29 . A method for treating at least one skin condition selected from the group consisting of itch, irritation, inflammation, loss of tone, redness, allergic responses, combination skin, blemishes, flushing and blushing, the method comprising topically applying to an affected area of the skin an effective amount of the composition of claim 1 .
30 . The method of claim 29 , wherein the composition is applied for an effective period of time.
31 . The method of claim 29 , wherein the composition is applied daily for about 2 weeks.
32 . The method of claim 29 , wherein the ingredient is present in an amount about 0.01 w % to about 50 wt % based on the total weight of the composition.
33 . The method of claim 29 , wherein the ingredient is 1,3,6-trihydroxy-7-methoxy-2,8-di (3-methyl-2-butenyl) xanthone.Join the waitlist — get patent alerts
Track US2003138467A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.